The International Trade Commission said Thursday it will investigate Chinese state support in the biotechnology sector as part of a pair of new probes looking at the U.S. trade relationship with ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

This clinical-stage biotech develops oral therapies targeting cancer and inflammatory diseases, with lead candidates in ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

The US International Trade Commission has initiated two significant Section 332(b) investigations that could shape the next phase of the United States’ China trade policy: one examining the economic ...

John Flavin , Portal Innovations CEO, joins 'Fast Money' to discuss if there is still room to run in the biotech space. Got a confidential news tip? We want to hear from you. Sign up for free ...

In today’s unpredictable global trade environment, with rising tariffs and tensions, investors are looking for stability. That means turning to assets that can hold up under pressure, especially those ...

Global investors in AI, machine learning, semiconductors, biotech, and data infrastructure face intersecting regulatory risks that affect talent, supply chains, governance, and exits. Those who ...

The South Koreans are way ahead in developing human embryonic stem cells to treat disease. China, now testing genetically engineered rice, looms as a threat to disrupt Monsanto Corp.'s broad grip on ...

Kentucky-based Aristides Capital sold 28,467 shares of IBB in the third quarter. The shares were worth an estimated $3.60 million. The move marked a full exit from the position, which was previously ...